Tucatinib is a highly selective, small-molecule tyrosine kinase inhibitor (TKI) targeting the HER2 receptor, primarily indicated for the treatment of HER2-positive breast cancer, including cases with brain… Read more
![Chemical structure of (2-((4-((4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)amino)quinazolin-6-yl)amino)-4-methyl-4,5-dihydrooxazol-4-yl)methanol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F937263-81-5-2-4-4-124Triazolo15-apyridin-7-yloxy-3-methylphenylaminoquinazolin-6-ylamino-4-methyl-45-dihydrooxazol-4-ylmethanol.png&w=3840&q=75)
![Chemical structure of 1-(4-((4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)amino)quinazolin-6-yl)-3-(1-hydroxy-2-methylpropan-2-yl)thiourea](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1429755-58-7-1-4-4-124Triazolo15-apyridin-7-yloxy-3-methylphenylaminoquinazolin-6-yl-3-1-hydroxy-2-methylpropan-2-ylthiourea.png&w=3840&q=75)
![Chemical structure of 1-(4-((4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)amino)quinazolin-6-yl)-4,4-dimethylimidazolidine-2-thione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2954734-92-8-1-4-4-124Triazolo15-apyridin-7-yloxy-3-methylphenylaminoquinazolin-6-yl-44-dimethylimidazolidine-2-thione.png&w=3840&q=75)
![Chemical structure of 2-Amino-2-methylpropyl (4-((4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)amino)quinazolin-6-yl)carbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-Amino-2-methylpropyl-4-4-124triazolo15-apyridin-7-yloxy-3-methylphenylaminoquinazolin-6-ylcarbamate.png&w=3840&q=75)

![Chemical structure of 3-(4-((4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)amino)quinazolin-6-yl)-1,1-dimethylthiourea](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3091639-36-7-3-4-4-124Triazolo15-apyridin-7-yloxy-3-methylphenylaminoquinazolin-6-yl-11-dimethylthiourea.png&w=3840&q=75)
![Chemical structure of 4,6-Quinazolinediamine, N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2307628-67-5-46-Quinazolinediamine-N4-3-methyl-4-124triazolo15-apyridin-7-yloxyphenyl.png&w=3840&q=75)
![Chemical structure of 4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylaniline](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F937263-71-3-4-124Triazolo15-apyridin-7-yloxy-3-methylaniline.png&w=3840&q=75)
![Chemical structure of 7-(2-Methyl-4-nitrophenoxy)-[1,2,4]triazolo[1,5-a]pyridine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F937263-44-0-7-2-Methyl-4-nitrophenoxy-124triazolo15-apyridine.png&w=3840&q=75)
![Chemical structure of N-(4-((4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)amino)quinazolin-6-yl)-N-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)nitrous amide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-4-4-124Triazolo15-apyridin-7-yloxy-3-methylphenylaminoquinazolin-6-yl-N-44-dimethyl-45-dihydrooxazol-2-ylnitrous-amide.png&w=3840&q=75)
![Chemical structure of N-(4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-6-nitroquinazolin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2307628-66-4-N-4-124Triazolo15-apyridin-7-yloxy-3-methylphenyl-6-nitroquinazolin-4-amine.png&w=3840&q=75)
![Chemical structure of N-(4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N-(6-((4,4-dimethyl-4,5-dihydrooxazol-2-yl)(nitroso)amino)quinazolin-4-yl)nitrous amide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-4-124Triazolo15-apyridin-7-yloxy-3-methylphenyl-N-6-44-dimethyl-45-dihydrooxazol-2-ylnitrosoaminoquinazolin-4-ylnitrous-amide.png&w=3840&q=75)
![Chemical structure of N-(4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N-(6-((4,4-dimethyl-4,5-dihydrooxazol-2-yl)amino)quinazolin-4-yl)nitrous amide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-4-124Triazolo15-apyridin-7-yloxy-3-methylphenyl-N-6-44-dimethyl-45-dihydrooxazol-2-ylaminoquinazolin-4-ylnitrous-amide.png&w=3840&q=75)
![Chemical structure of N-(4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N-(6-nitroquinazolin-4-yl)nitrous amide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-4-124Triazolo15-apyridin-7-yloxy-3-methylphenyl-N-6-nitroquinazolin-4-ylnitrous-amide.png&w=3840&q=75)

![Chemical structure of N4-(4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrothiazol-2-yl)quinazoline-4,6-diamine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F937266-01-8-N4-4-124Triazolo15-apyridin-7-yloxy-3-methylphenyl-N6-44-dimethyl-45-dihydrothiazol-2-ylquinazoline-46-diamine.png&w=3840&q=75)



Tucatinib is a highly selective, small-molecule tyrosine kinase inhibitor (TKI) targeting the HER2 receptor, primarily indicated for the treatment of HER2-positive breast cancer, including cases with brain metastases. This category provides a comprehensive collection of Tucatinib reference standards, including the active pharmaceutical ingredient, its metabolites, and structurally characterized process and degradation-related impurities. Pharmaceutical laboratories require these specialized compounds for rigorous quality control and impurity profiling. Stable isotope-labeled compounds, such as deuterated analogues, are essential for accurate quantification in complex matrices, serving as reliable internal standards during LC-MS/MS analytical method validation. These reference materials support adherence to regulatory standards by facilitating the precise identification and quantification of impurities formed during manufacturing or stress testing, such as oxidative or hydrolytic degradation products.